Search

Author/Creator Hassell, Thomas

1. CGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate. Issue 4 (11th December 2017)

Authors:
Dey, Antu K.; Cupo, Albert; Ozorowski, Gabriel; Sharma, Vaneet K.; Behrens, Anna‐Janina; Go, Eden P.; Ketas, Thomas J.; Yasmeen, Anila; Klasse, Per J.; Sayeed, Eddy; Desaire, Heather; Crispin, Max; Wilson, Ian A.; Sanders, Rogier W.; Hassell, Thomas; Ward, Andrew B.; Moore, John P.
Journal:
Biotechnology and bioengineering
Issue:
Volume 115:Issue 4(2018)
Page Start:
885
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Rapid cGMP manufacturing of COVID‐19 monoclonal antibody using stable CHO cell pools. Issue 2 (10th December 2021)

Authors:
Agostinetto, Rita; Rossi, Mara; Dawson, Jessica; Lim, Angela; Simoneau, Mirva H.; Boucher, Cyril; Valldorf, Bernhard; Ross‐Gillespie, Adin; Jardine, Joseph G.; Sok, Devin; Burton, Dennis R.; Hassell, Thomas; Broly, Hervé; Palinsky, Wolf; Dupraz, Philippe; Feinberg, Mark; Dey, Antu K.
Journal:
Biotechnology and bioengineering
Issue:
Volume 119:Issue 2(2022)
Page Start:
663
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search